Araştırma Makalesi

Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis?

Cilt: 42 Sayı: 6 9 Kasım 2020
PDF İndir
EN TR

Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis?

Öz

Leptomeningeal carcinomatosis (LMC) is caused by the spread of malignant cells within cerebrospinal fluid (CSF). Diffusion-weighted imaging (DWI) is quantified by the apparent diffusion coefficient (ADC) value. The decreased ADC of CSF in pyogenic ventriculitis due to pleocytosis and the protein content has been reported. With similar argument, we hypothesized ADC in LMC can be decreased due to higher CSF viscosity caused by levated factors such as cell count, total protein. The purpose of our study was to evaluate whether increased CSF viscosity in LMC causes low ADC values in CSF. Thirty-one patients with LMC and 31 age and sex-matched subjects having normal brain MRI were included in this study. ADC measurements were made on both sides in posterior lateral ventricle (LV) and lateral pterigoid muscle (LPM). The ADC ratio (=ADCCSF/ADCLPM) was calculated by dividing the ADC values to prevent individual and device-dependent differences. ADCCSF and ADC ratios were compared between the groups. Both the ADCCSF and ADCCSF/ADCLPM ratio in the LMC group was lower than those in the control group with statistical significance. ROC analysis showed a cutoff value of 2844 for the ADCCSF (sensitivity 51.61%, specificity 96.77%, under curve 0.800) and a cutoff value of 1.97 for the ADC ratio (sensitivity 74.19%, specificity 93.55%, under curve 0.833) for differentiating LMC and control groups. ADC value may be used as a complementary tool to increase diagnostic accuracy of LMC.

Anahtar Kelimeler

Kaynakça

  1. 1. Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013;4(Suppl 4):S265-88.
  2. 2. El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, et al. Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis. Cancer Manag Res. 2019;11:789-801.
  3. 3. Leal T, Chang JE, Mehta M, Robins HI. Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment. Curr Cancer Ther Rev. 2011;7(4):319-27.
  4. 4. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers. http://www.nccn.org/professionals/physician_gls/pdf/cnspdf. 2016
  5. 5. Hyun JW, Park JH, Kang BG, Park EY, Park B, Joo J, et al. Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis. Oncotarget. 2017;8(32):53326-35.
  6. 6. Gil B, Hwang EJ, Lee S, Jang J, Choi HS, Jung SL, Ahn KJ, Kim BS. Detection of Leptomeningeal Metastasis by Contrast-Enhanced 3D T1-SPACE: Comparison with 2D FLAIR and Contrast-Enhanced 2D T1-Weighted Images. PLoS One. 2016;11(10):e0163081.
  7. 7. Debnam JM, Mayer RR, Chi TL, Ketonen L, Weinberg JS, Wei W, Groves MD, Guha-Thakurta N. Most common sites on MRI of intracranial neoplastic leptomeningeal disease. J Clin Neurosci. 2017;45:252-6. 8. Vaswani AK, Nizamani WM, Ali M, Aneel G, Shahani BK, Hussain S. Diagnostic Accuracy of Contrast-Enhanced FLAIR Magnetic Resonance Imaging in Diagnosis of Meningitis Correlated with CSF Analysis. ISRN Radiol. 2014;2014:578986.
  8. 9. Gupta PK, Awasthi R, Singh S, Behari S, Maria Das KJ, Gupta RK, Kumar S. Value of Minimum Apparent Diffusion Coefficient on Magnetic Resonance Imaging as a Biomarker for Predicting Progression of Disease Following Surgery and Radiotherapy in Glial Tumors from a Tertiary Care Center in Northern India. J Neurosci Rural Pract. 2017;8(2):185-93.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

9 Kasım 2020

Gönderilme Tarihi

17 Nisan 2020

Kabul Tarihi

4 Haziran 2020

Yayımlandığı Sayı

Yıl 2020 Cilt: 42 Sayı: 6

Kaynak Göster

APA
Şaylısoy, S., & Toprak, U. (2020). Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis? Osmangazi Tıp Dergisi, 42(6), 699-704. https://doi.org/10.20515/otd.721757
AMA
1.Şaylısoy S, Toprak U. Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis? Osmangazi Tıp Dergisi. 2020;42(6):699-704. doi:10.20515/otd.721757
Chicago
Şaylısoy, Suzan, ve Uğur Toprak. 2020. “Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis?”. Osmangazi Tıp Dergisi 42 (6): 699-704. https://doi.org/10.20515/otd.721757.
EndNote
Şaylısoy S, Toprak U (01 Kasım 2020) Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis? Osmangazi Tıp Dergisi 42 6 699–704.
IEEE
[1]S. Şaylısoy ve U. Toprak, “Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis?”, Osmangazi Tıp Dergisi, c. 42, sy 6, ss. 699–704, Kas. 2020, doi: 10.20515/otd.721757.
ISNAD
Şaylısoy, Suzan - Toprak, Uğur. “Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis?”. Osmangazi Tıp Dergisi 42/6 (01 Kasım 2020): 699-704. https://doi.org/10.20515/otd.721757.
JAMA
1.Şaylısoy S, Toprak U. Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis? Osmangazi Tıp Dergisi. 2020;42:699–704.
MLA
Şaylısoy, Suzan, ve Uğur Toprak. “Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis?”. Osmangazi Tıp Dergisi, c. 42, sy 6, Kasım 2020, ss. 699-04, doi:10.20515/otd.721757.
Vancouver
1.Suzan Şaylısoy, Uğur Toprak. Is Lateral Ventricle Apparent Diffusion Coefficient Value Useful In The Diagnosis of Leptomeningeal Carcinomatosis? Osmangazi Tıp Dergisi. 01 Kasım 2020;42(6):699-704. doi:10.20515/otd.721757


13299        13308       13306       13305    13307  1330126978